Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.755    -0.045 (-2.50%)
Bid:
1.505
Ask:
1.845
Spread: 0.34 (22.591%)
Market Cap: £35.21m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Agreement with Euthenia & BTG Bioliquids

15 Feb 2024 07:00

RNS Number : 1953D
Quadrise PLC
15 February 2024
 

15 February 2024

Quadrise Plc ("Quadrise" or the "Company")

Project Development Agreement with Euthenia and BTG Bioliquids

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to announce the signature of a Project Development Agreement ("PDA") with renewable biofuels specialists, BTG Bioliquids BV ("BTL") and Euthenia Energy Group Limited ("Euthenia").

As announced on 8 June 2023, Quadrise and BTL entered into a Joint Development Agreement ("JDA") to investigate the use of BTL's fast pyrolysis bio-oil ("FPBO") as a potential cost-effective renewable feedstock for Quadrise's bioMSAR? solution. The JDA forms part of our strategy to deliver a commercially viable net-zero biofuel by 2030 whilst also supporting decarbonisation of the marine, power, and heavy industry sectors. Work carried out under the JDA has resulted in positive outcomes to date, with stable formulations of bioMSAR? incorporating FPBO ("Pyrolytic bioMSAR?") being produced at the Quadrise Research Facility.

Building on this success, Quadrise and BTL have signed the PDA with Euthenia, an industrial group that is focused on developing, financing, and operating renewable energy projects and transition solutions for a low carbon economy. Euthenia have active projects and operations in Europe, North America and the Caribbean.

Under the PDA, a programme of lab and pilot testing, followed by diesel engine testing, is planned leading to a third-party commercial marine vessel trial. Euthenia will process ligno-cellulosic biomass feedstock at their facilities in Spain using BTL's FPBO and fractionation technologies, with the extracted sugars blended into Pyrolytic bioMSAR? to provide sustainable marine fuel.

The work envisaged under the PDA is expected to accelerate the development of Pyrolytic bioMSAR? and bioMSAR? Zero to serve global shipping fleets in the Mediterranean, widen the global opportunities for BTL FPBO technology and leverage Euthenia's successful bioenergy and decarbonisation business.

A binding term sheet is expected to be finalised and signed within four months of signing the PDA to cover the larger diesel engine tests, the marine vessel trial and the future commercial relationships between the parties.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

"Quadrise is pleased with the progress made with BTG Bioliquids to date, and we are delighted to be now working alongside Euthenia under this new tripartite agreement. Advanced biofuels derived from woody biomass are expected to be very price competitive net-zero feedstocks. Importantly, the extracted sugars are water-soluble and therefore particularly suited for use with our oil-in-water emulsion technology for shipping and industrial applications. This latest collaboration is part of our wider plan to commercialise bioMSAR? sustainable marine fuel in major bunker hubs, as well as advancing our programme to supply bioMSAR? Zero by 2030 to reduce sector emissions of greenhouse gases and other pollutants using existing infrastructure.

Gerhard Muggen, Managing Director of BTG Bioliquids, added:

"BTG Bioliquids is pleased to have signed this latest agreement with Quadrise and Euthenia to accelerate our strategy of collaborating with partners to develop attractive applications for fast pyrolysis bio-oil technology. The successful inclusion of fast pyrolysis bio-oils and their derivatives into bioMSAR? will be a major step in decarbonising the shipping industry."

Jean Paul Chalot, Chairman of Euthenia Energy Group, concluded:

"Euthenia is pleased to initiate this major project in collaboration with BTG Bioliquids and Quadrise as technology partners, using our industrial site in Spain, leveraged by a unique background in the biomass industry and a location nearby the major Mediterranean bunker hubs of Algeciras and Gibraltar. Advanced renewable transportation fuels derived from biomass present a very disruptive alternative for the aviation and shipping industries. With the successful outcome of this Project, we will confirm our ambition with our partners to be a major player in the sustainable marine fuel industry."

 

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay Thomson

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR? emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

Learn more about BTG Bioliquids at: www.btg-bioliquids.com

Learn more about Euthenia Energy at: www.euthenia-energy.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQKQBQKBKBQBD
Date   Source Headline
12th Jun 20267:00 amRNSValkor update
15th Apr 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSInterim Results & Notice of Investor Presentation
19th Mar 20267:00 amRNSAppointment of Non-Executive Director
3rd Feb 20267:00 amRNS-RPublication of 2025 Sustainability Report
12th Jan 20267:00 amRNSExtension of Exclusive Agreement with Nouryon
9th Jan 20267:00 amRNSDirector/PDMR Shareholding and Directorate Change
4th Dec 202512:17 pmRNSDirector/PDMR Shareholding
28th Nov 20252:55 pmRNSResult of AGM
28th Nov 20257:00 amRNSAGM Statement
7th Nov 20253:01 pmRNSDirector/PDMR Shareholding
6th Nov 20251:46 pmRNSDirector/PDMR Shareholding
28th Oct 20255:23 pmRNSPosting of Annual Report and Notice of AGM
27th Oct 20257:00 amRNSIssue of Options and Director Dealing
13th Oct 20257:00 amRNSIssue of Share Options and Director/PDMR Dealing
29th Sep 20257:00 amRNSFinal Results and Notice of AGM
26th Sep 20257:00 amRNSValkor update
17th Sep 20257:00 amRNSSuccessful Sparkle Power Programme Testing
15th Sep 20257:00 amRNSCEO Appointment
18th Aug 20257:00 amRNSBusiness Update
25th Jul 20257:00 amRNSDirector / PDMR Shareholding
14th Jul 20258:00 amRNSDirector/PDMR Shareholding
4th Jul 202511:50 amRNSExercise of Options and Total Voting Rights
17th Jun 20257:00 amRNSJoint Development Agreement with Alder Energy LLC
10th Jun 20257:00 amRNSBusiness Update
23rd May 20257:00 amRNSExercise of Warrants
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSManagement Update
3rd Apr 20257:00 amRNSExercise of Share Options
1st Apr 20257:00 amRNSMAC2 Services Agreement
26th Mar 202512:46 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSLicella Joint Development Agreement
24th Mar 20257:00 amRNSInterim Results and Investor Presentation
13th Mar 20257:00 amRNS-RAppointment of Head of Marine
31st Jan 20257:00 amRNSResult of Retail Offer
30th Jan 20252:36 pmRNSIncrease of Retail Offer
28th Jan 20257:00 amRNSAppointment of Director
24th Jan 202510:04 amRNSRetail Offer - Notice of IMC Presentation
24th Jan 20257:05 amRNSRetail Offer
24th Jan 20257:00 amRNSResult of Placing and Subscription
23rd Jan 20254:51 pmRNSProposed Placing, Subscription and Retail Offer
15th Jan 20257:00 amRNSValkor License Revenues
16th Dec 20247:00 amRNSMaterial Transfer Agreement with Sparkle Power SA
5th Dec 20247:00 amRNS-RbioMSAR™ Development Update
26th Nov 20247:00 amRNSProject Agreement with MSC and Cargill
25th Nov 20247:00 amRNSCollaboration Agreement with Auramarine
22nd Nov 20244:57 pmRNSResult of AGM
22nd Nov 20247:00 amRNSAGM Statement
25th Oct 20244:05 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20247:00 amRNSFinal Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.